Asahi Kasei Therapeutics Corp - Company Profile
Powered by 
All the sales intelligence you need on Asahi Kasei Therapeutics Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Asahi Kasei Therapeutics Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Asahi Kasei Therapeutics Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Asahi Kasei Therapeutics Corp Catalyst Calendar
Proactively evaluate Asahi Kasei Therapeutics Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Asahi Kasei Therapeutics Corp Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 15 May 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 05 Feb 2021 | Phase I Trial Initiation | Asahi Kasei Pharma Corp | - | AK-1830 | Central Nervous System; Immunology; Musculoskeletal Disorders | Inflammation; Low Back Pain; Osteoarthritis; Osteoarthritis Pain | Clinical Trial Registry |
| 01 Aug 2020 | Phase I Trial Initiation | Asahi Kasei Pharma Corp; Emergent Clinical Consulting LLC | - | AK-1320 | Central Nervous System; Musculoskeletal Disorders | Degenerative Spondylolisthesis; Radiculopathy; Spinal Stenosis | Clinical Trial Registry |
| 15 Jan 2020 | Phase II Trial Initiation | Asahi Kasei Pharma Corp | - | AK-1830 | Central Nervous System; Musculoskeletal Disorders | Osteoarthritis; Osteoarthritis Pain | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer